Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial

The Lancet

Volumn 389, Issue 10072, 2017, Pages 909-916

  Ravelli, Angelo ^a,b   Davì, Sergio ^a   Bracciolini, Giulia ^b   Pistorio, Angela ^a   Consolaro, Alessandro ^a,b   van Dijkhuizen, Evert Hendrik Pieter ^a   Lattanzi, Bianca ^c   Filocamo, Giovanni ^d   Verazza, Sara ^b   Gerloni, Valeria ^e   Gattinara, Maurizio ^e   Pontikaki, Irene ^e   Insalaco, Antonella ^f   De Benedetti, Fabrizio ^f   Civino, Adele ^g   Presta, Giuseppe ^g   Breda, Luciana ^h   Marzetti, Valentina ^h   Pastore, Serena ⁱ   Magni Manzoni, Silvia ^f   Maggio, Maria Cristina ^j   Garofalo, Franco ^k   Rigante, Donato ^l   Gattorno, Marco ^a   Malattia, Clara ^a,b   Picco, Paolo ^a   Viola, Stefania ^a   Lanni, Stefano ^a   Ruperto, Nicolino ^a   Martini, Alberto ^a,b   more..

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g Medicina di Laboratorio   (Italy)

^h Policlinico   (Italy)

ⁱ INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^j UNIVERSITY OF PALERMO   (Italy)

^k OSPEDALE DEGLI INFERMI   (Italy)

^l FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE ACETATE; TRIAMCINOLONE HEXACETONIDE; CORTICOSTEROID;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; COMBINATION DRUG THERAPY; CONSTIPATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; HYPOPIGMENTATION; INJECTION SITE REACTION; IRRITABILITY; ITALY; JUVENILE RHEUMATOID ARTHRITIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS; OPEN STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; SKIN ATROPHY; SYSTEMIC DISEASE; VOMITING; INTRAARTICULAR DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ARTHRITIS, JUVENILE; HUMANS; INJECTIONS, INTRA-ARTICULAR; ITALY; METHOTREXATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85011292253     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)30065-X     Document Type: Article

References (30)

1. 1 Petty, RE, Southwood, TR, Manners, P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31 (2004), 390–392.
2. 2 Ravelli, A, Martini, A, Juvenile idiopathic arthritis. Lancet 369 (2007), 767–778.
3. 3 Wallace, CA, Huang, B, Bandeira, M, Ravelli, A, Giannini, EH, Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 52 (2005), 3554–3562.
4. 4 Vidqvist, KL, Malin, M, Varjolahti-Lehtinen, T, Korpela, MM, Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology 52 (2013), 1999–2003.
5. 5 Consolaro, A, Ravelli, A, Unraveling the phenotypic variability of juvenile idiopathic arthritis across races or geographic areas—key to understanding etiology and genetic factors?. J Rheumatol 43 (2016), 683–685.
6. 6 Guillaume, S, Prieur, AM, Coste, J, Job-Deslandre, C, Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 43 (2000), 1858–1865.
7. 7 Oen, K, Malleson, PN, Cabral, DA, Rosenberg, AM, Petty, RE, Cheang, M, Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 29 (2002), 1989–1999.
8. 8 Lovell, DJ, Ruperto, N, Giannini, EH, Martini, A, Advances from clinical trials in juvenile idiopathic arthritis. Nat Rev Rheumatol 9 (2013), 557–563.
9. 9 Ruperto, N, Nikishina, I, Pachanov, ED, et al. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: Short-and long-term efficacy and safety results. Arthritis Rheum 52 (2005), 563–572.
10. 10 Reiff, A, Lovell, DJ, Adelsberg, JV, et al. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol 33 (2006), 985–995.
11. 11 Sobel, RE, Lovell, DJ, Brunner, HI, et al. Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry. Pediatr Rheumatol Online J, 12, 2014, 29.
12. 12 Zulian, F, Martini, G, Gobber, D, Plebani, M, Zacchello, F, Manners, P, Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology 43 (2004), 1288–1291.
13. 13 Beukelman, T, Guevara, JP, Albert, DA, Sherry, DD, Burnham, JM, Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada. J Rheumatol 34 (2007), 1918–1924.
14. 14 Beukelman, T, Patkar, NM, Saag, KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 63 (2011), 465–482.
15. 15 Scott, C, Meiorin, S, Filocamo, G, et al. A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol 28 (2010), 774–781.
16. 16 Bloom, BJ, Alario, AJ, Miller, LC, Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review. Rheumatol Int 31 (2011), 749–756.
17. 17 Sherry, DD, Stein, LD, Reed, AM, Schanberg, LE, Kredich, DW, Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 42 (1999), 2330–2334.
18. 18 Lanni, S, Bertamino, M, Consolaro, A, et al. Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. Rheumatology 50 (2011), 1627–1634.
19. 19 Giannini, EH, Brewer, EJ, Kuzmina, N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 326 (1992), 1043–1049.
20. 20 Ruperto, N, Murray, KJ, Gerloni, V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50 (2004), 2191–2201.
21. 21 Papadopoulou, C, Kostik, M, Bohm, M, et al. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. J Pediatr 163 (2013), 879–884.
22. 22 Papadopoulou, C, Kostik, M, Gonzalez-Fernandez, MI, et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res 65 (2013), 1112–1120.
23. 23 Marti, P, Molinari, L, Bolt, IB, Seger, R, Saurenmann, RK, Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 167 (2008), 425–430.
24. 24 Wallace, CA, Giannini, EH, Huang, B, Itert, L, Ruperto, N, American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res 63 (2011), 929–936.
25. 25 Consolaro, A, Negro, G, Chiara Gallo, M, et al. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care Res 66 (2014), 1703–1709.
26. 26 Van Buuren, S, Groothuis-Oudshoorn, K, Mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45 (2011), 1–67.
27. 27 Felici, E, Novarini, C, Magni-Manzoni, S, et al. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. J Rheumatol 32 (2005), 1805–1810.
28. 28 Klein, A, Kaul, I, Foeldvari, I, Ganser, G, Urban, A, Horneff, G, Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry. Arthritis Care Res 64 (2012), 1349–1356.
29. 29 Bianchi, G, Caporali, R, Todoerti, M, Mattana, P, Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration. Adv Ther 33 (2016), 369–378.
30. 30 Alsufyani, K, Ortiz-Alvarez, O, Cabral, DA, Tucker, LB, Petty, RE, Malleson, PN, The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. J Rheumatol 31 (2004), 179–182.